| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP, Technical Operations | SVP, Technical Operations
1 company
Jayant Aphale last filed a Form 4 in September 2016, as VP, Technical Operations at SRPT. Jayant Aphale's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 11,490 shares of SRPT. The SRPT filings lean toward selling, a net 35,000 shares.
Jayant Aphale has 4 Form 4 filings on record from February 2015 to September 2016, all as VP, Technical Operations at Sarepta Therapeutics (SRPT), 2015–2016.
The 12 reported transactions were 6 option or other derivative awards, 2 option exercises, 2 open-market sales and 1 tax withholding, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $1.8M.
The only open-market sale was 35,000 shares of SRPT at an average $50.00 on September 19, 2016, about $1.8M.
Shares as reported in the last Form 4 for each company; the most recent is from September 2016. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 19, 2016 | SRPT Sarepta Therapeutics, Inc. | VP, Technical Operations | Sale+OE | 35,000 | $50.00 | $1,750,000.00 | -75.3% |